Filter the latest scan's published facts — sector, size, yield, valuation — or rank them with a preset: cheapest, fastest growing, most profitable. Every view shows what is in the filings and prices; none ranks opportunity. The model behind the statuses showed no predictive power, and nothing here is a recommendation.
Scan of 2026-08-31 · 2,409 names scored · prices as of that date
285 names match — page 2 of 3 · Export CSV
| Ticker | Company | Sector | Market cap ↑ | P/E | P/B | Div. yield | 1M change | Composite %ile | Status |
|---|---|---|---|---|---|---|---|---|---|
| REPL | Replimune Group, Inc. | Pharma & chemicals | $1.27B | — |
Figures are as of the scan date, from unadjusted prices and point-in-time filings. "—" means the scan published no figure — deliberately, where a ratio's denominator made it meaningless. A hole is honest; a confidently wrong number is not. "Composite %ile" is the position in a ranking with no measurable predictive power — context for the status, not a score.
Never the absolute multiple alone. A P/E of 9 is a fact; whether it is low depends on what you hold it against.
The five-year window is the empirically privileged one. Cheap against its sector and cheap against its own history are different claims, and a stock can be one without being the other — which is the whole reason both columns are shown rather than blended into a single score.
| 7.62 |
| — |
| up 36.61% |
| 9.8 |
pass |
| MAZE | Maze Therapeutics, Inc. Common Stock | Pharma & chemicals | $1.32B | — | 3.87 | — | down 1.30% | 17.6 | pass |
| EPC | Edgewell Personal Care Company | Pharma & chemicals | $1.32B | 52.1 | 0.91 | 2.09% | up 5.63% | 45.4 | pass |
| UAN | CVR Partners, LP | Pharma & chemicals | $1.34B | 13.5 | 4.29 | 11.45% | down 2.01% | 89.4 | pass |
| ORIC | Oric Pharmaceuticals, Inc. Common Stock | Pharma & chemicals | $1.34B | — | 3.23 | — | up 17.34% | 7.0 | pass |
| REX | REX American Resources Corp. | Pharma & chemicals | $1.35B | 14.2 | 2.15 | — | down 4.55% | 91.4 | pass |
| CGEM | Cullinan Therapeutics, Inc. Common Stock | Pharma & chemicals | $1.36B | — | 3.32 | — | up 33.76% | 19.1 | pass |
| AVBP | ArriVent BioPharma, Inc. Common Stock | Pharma & chemicals | $1.36B | — | 4.20 | — | up 0.77% | 19.6 | pass |
| HROW | Harrow, Inc. Common Stock | Pharma & chemicals | $1.38B | — | 47.92 | — | down 4.80% | 5.7 | pass |
| ABSI | Absci Corporation Common Stock | Pharma & chemicals | $1.40B | — | 8.17 | — | up 16.20% | 13.5 | pass |
| SCL | Stepan Co. | Pharma & chemicals | $1.43B | 30.5 | 1.20 | 1.89% | down 2.39% | 61.0 | pass |
| REGN | Regeneron Pharmaceuticals Inc | Pharma & chemicals | $1.44B | 0.3 | 0.05 | 0.46% | up 4.78% | 98.3 | watch |
| SDGR | Schrodinger, Inc. Common Stock | Pharma & chemicals | $1.45B | — | 4.64 | — | up 28.80% | 4.9 | pass |
| NKTR | Nektar Therapeutics | Pharma & chemicals | $1.45B | — | 2.52 | — | up 1.00% | 22.6 | pass |
| XERS | Xeris Biopharma Holdings, Inc. Common Stock | Pharma & chemicals | $1.46B | — | — | — | up 4.46% | 14.3 | pass |
| TYRA | Tyra Biosciences, Inc. Common Stock | Pharma & chemicals | $1.49B | — | 3.84 | — | down 21.49% | 26.1 | pass |
| BCAX | Bicara Therapeutics Inc. Common Stock | Pharma & chemicals | $1.52B | — | 2.95 | — | down 14.69% | 28.0 | pass |
| PAHC | Phibro Animal Health Corporation Class A | Pharma & chemicals | $1.53B | 31.7 | 4.23 | 1.27% | up 3.88% | 33.7 | pass |
| INVA | Innoviva, Inc. Common Stock | Pharma & chemicals | $1.53B | 5.7 | 1.14 | — | down 0.95% | 94.0 | pass |
| NTLA | Intellia Therapeutics, Inc | Pharma & chemicals | $1.53B | — | 2.47 | — | up 19.19% | 3.1 | pass |
| TSHA | Taysha Gene Therapies, Inc. Common Stock | Pharma & chemicals | $1.63B | — | 7.71 | — | down 2.90% | 14.1 | pass |
| ETON | Eton Pharmaceutcials, Inc. Common Stock | Pharma & chemicals | $1.65B | — | 54.01 | — | up 30.20% | 21.5 | pass |
| ANAB | AnaptysBio, Inc. Common Stock | Pharma & chemicals | $1.66B | — | — | — | up 6.88% | 16.6 | pass |
| HUN | Huntsman Corporation | Pharma & chemicals | $1.66B | — | 0.62 | 5.35% | down 1.84% | 14.8 | pass |
| ANIP | ANI Pharmaceuticals, Inc. | Pharma & chemicals | $1.68B | 21.4 | 2.98 | — | down 7.56% | 54.9 | pass |
| DMRA | Damora Therapeutics, Inc. Ordinary Shares | Pharma & chemicals | $1.70B | — | 3.32 | — | down 2.79% | 18.6 | pass |
| SNDX | Syndax Pharmaceuticals, Inc. | Pharma & chemicals | $1.71B | — | 41.04 | — | up 1.26% | 7.6 | pass |
| SEPN | Septerna, Inc. Common Stock | Pharma & chemicals | $1.71B | — | 4.53 | — | up 10.74% | 26.7 | pass |
| VIR | Vir Biotechnology, Inc. Common Stock | Pharma & chemicals | $1.76B | — | 2.17 | — | up 26.33% | 22.5 | pass |
| STOK | Stoke Therapeutics, Inc. Common Stock | Pharma & chemicals | $1.94B | — | 4.92 | — | up 8.11% | 27.1 | pass |
| MRVI | Maravai LifeSciences Holdings, Inc. Class A Common Stock | Pharma & chemicals | $1.97B | — | 9.32 | — | up 16.29% | 18.1 | pass |
| OLN | Olin Corp. | Pharma & chemicals | $1.98B | — | 1.14 | 4.60% | down 6.00% | 13.7 | pass |
| AGIO | Agios Pharmaceuticals, Inc. | Pharma & chemicals | $2.00B | — | 1.80 | — | up 12.19% | 4.3 | pass |
| ZBIO | Zenas BioPharma, Inc. Common Stock | Pharma & chemicals | $2.02B | — | 6.00 | — | up 2.80% | 11.2 | pass |
| XNCR | Xencor, Inc. | Pharma & chemicals | $2.02B | — | 3.92 | — | up 34.91% | 26.4 | pass |
| PRGO | PERRIGO COMPANY PLC | Pharma & chemicals | $2.02B | — | 0.81 | 5.94% | up 44.81% | 6.3 | pass |
| VCEL | Vericel Corporation | Pharma & chemicals | $2.04B | 123.2 | 5.71 | — | down 13.19% | 33.9 | pass |
| AUPH | Aurinia Pharmaceuticals Inc | Pharma & chemicals | $2.11B | 7.3 | 3.71 | — | up 8.27% | 86.6 | pass |
| MLYS | Mineralys Therapeutics, Inc. Common Stock | Pharma & chemicals | $2.12B | — | 3.32 | — | up 0.59% | 16.9 | pass |
| TRVI | Trevi Therapeutics, Inc. Common Stock | Pharma & chemicals | $2.13B | — | 12.38 | — | down 9.04% | 23.2 | pass |
| ZYME | Zymeworks Inc. | Pharma & chemicals | $2.15B | — | 13.14 | — | up 34.05% | 17.0 | pass |
| ADMA | ADMA Biologics, Inc. | Pharma & chemicals | $2.18B | 14.8 | 5.59 | — | up 10.99% | 37.1 | pass |
| PVLA | Palvella Therapeutics, Inc. Common Stock | Pharma & chemicals | $2.18B | — | 9.40 | — | up 9.75% | 19.9 | pass |
| SRPT | Sarepta Therapeutics,, Inc. Common Stock | Pharma & chemicals | $2.22B | — | 1.48 | — | up 41.52% | 4.4 | pass |
| MTX | Minerals Technologies Inc | Pharma & chemicals | $2.23B | — | 1.29 | 0.68% | down 6.98% | 51.1 | pass |
| ROG | Rogers Corporation | Pharma & chemicals | $2.24B | — | 1.87 | — | up 1.70% | 42.8 | pass |
| HRMY | Harmony Biosciences Holdings, Inc. Common Stock | Pharma & chemicals | $2.28B | 14.4 | 2.50 | — | up 11.75% | 54.2 | pass |
| OCUL | Ocular Therapeutix, Inc. | Pharma & chemicals | $2.30B | — | 3.95 | — | up 28.40% | 2.2 | pass |
| BHVN | Biohaven Ltd. | Pharma & chemicals | $2.30B | — | 17.75 | — | up 13.11% | 1.0 | pass |
| NUVB | Nuvation Bio Inc. | Pharma & chemicals | $2.31B | — | 7.22 | — | up 5.21% | 13.9 | pass |
| KOD | Kodiak Sciences Inc Common Stock | Pharma & chemicals | $2.32B | — | 20.71 | — | down 10.17% | 10.9 | pass |
| RAPP | Rapport Therapeutics, Inc. Common Stock | Pharma & chemicals | $2.33B | — | 4.93 | — | up 18.77% | 17.9 | pass |
| IOSP | Innospec Inc. | Pharma & chemicals | $2.34B | 20.0 | 1.74 | 1.91% | up 9.16% | 69.1 | pass |
| CC | The Chemours Company | Pharma & chemicals | $2.34B | — | 10.88 | 2.25% | down 6.32% | 5.2 | pass |
| VRDN | Viridian Therapeutics, Inc. Common Stock | Pharma & chemicals | $2.37B | — | 3.73 | — | up 22.41% | 5.4 | pass |
| NGVT | Ingevity Corporation | Pharma & chemicals | $2.42B | — | 62.14 | — | down 5.22% | 17.1 | pass |
| SLS | SELLAS Life Sciences Group, Inc. Common Stock | Pharma & chemicals | $2.42B | — | 22.52 | — | up 33.27% | 17.0 | pass |
| VERA | Vera Therapeutics, Inc. Class A Common Stock | Pharma & chemicals | $2.44B | — | 4.89 | — | up 6.17% | 15.9 | pass |
| PGEN | Precigen, Inc. Common Stock | Pharma & chemicals | $2.47B | — | — | — | up 10.53% | 6.2 | pass |
| NEOG | Neogen Corp | Pharma & chemicals | $2.52B | — | 1.20 | — | down 3.99% | 31.0 | pass |
| SUPN | Supernus Pharmaceuticals, Inc. | Pharma & chemicals | $2.57B | — | 2.38 | — | down 0.94% | 26.6 | pass |
| CLDX | Celldex Therapeutics, Inc | Pharma & chemicals | $2.64B | — | 5.78 | — | up 4.13% | 23.1 | pass |
| NRIX | Nurix Therapeutics, Inc. Common stock | Pharma & chemicals | $2.67B | — | 5.54 | — | up 11.07% | 22.0 | pass |
| ATAI | AtaiBeckley Inc. Common Stock | Pharma & chemicals | $2.68B | — | 13.51 | — | up 2.23% | 8.6 | pass |
| ALMS | Alumis Inc. Common Stock | Pharma & chemicals | $2.77B | — | 4.89 | — | down 22.80% | 17.4 | pass |
| WDFC | Wd-40 Co | Pharma & chemicals | $2.88B | 31.7 | 10.72 | 1.87% | down 5.72% | 63.7 | pass |
| PBH | Prestige Consumer Healthcare Inc. | Pharma & chemicals | $2.91B | 15.3 | 1.54 | — | up 3.11% | 53.4 | pass |
| MBX | MBX Biosciences, Inc. Common Stock | Pharma & chemicals | $2.93B | — | 6.69 | — | down 6.57% | 19.2 | pass |
| FUL | H.B. Fuller Company | Pharma & chemicals | $2.96B | 19.4 | 1.42 | 1.75% | down 0.63% | 49.3 | pass |
| NAMS | NewAmsterdam Pharma Company N.V. Ordinary Shares | Pharma & chemicals | $2.96B | — | 4.44 | — | down 8.82% | 11.9 | pass |
| ARQT | Arcutis Biotherapeutics, Inc. Common Stock | Pharma & chemicals | $3.00B | — | 15.80 | — | down 10.76% | 25.5 | pass |
| IRON | Disc Medicine, Inc. Common Stock | Pharma & chemicals | $3.00B | — | 4.36 | — | up 2.14% | 17.8 | pass |
| BEAM | Beam Therapeutics Inc. Common Stock | Pharma & chemicals | $3.02B | — | 2.60 | — | up 15.32% | 24.0 | pass |
| QURE | uniQure N.V. | Pharma & chemicals | $3.07B | — | 20.55 | — | up 11.57% | 10.5 | pass |
| IMNM | Immunome, Inc. | Pharma & chemicals | $3.10B | — | 5.27 | — | up 20.43% | 20.9 | pass |
| TARS | Tarsus Pharmaceuticals, Inc. Common Stock | Pharma & chemicals | $3.19B | — | 9.15 | — | up 25.75% | 11.7 | pass |
| TNGX | Tango Therapeutics, Inc. | Pharma & chemicals | $3.29B | — | 8.41 | — | down 15.97% | 18.1 | pass |
| RLAY | Relay Therapeutics, Inc. Common Stock | Pharma & chemicals | $3.48B | — | 5.42 | — | down 2.39% | 21.8 | pass |
| ABCL | AbCellera Biologics Inc. Common Shares | Pharma & chemicals | $3.49B | — | 3.72 | — | up 101.05% | 13.1 | pass |
| IDYA | IDEAYA Biosciences, Inc. Common Stock | Pharma & chemicals | $3.52B | — | 3.76 | — | up 12.96% | 28.5 | pass |
| ELVN | Enliven Therapeutics, Inc. Common Stock | Pharma & chemicals | $3.52B | — | 7.77 | — | up 5.62% | 20.1 | pass |
| IOVA | Iovance Biotherapeutics, Inc. Common Stock | Pharma & chemicals | $3.58B | — | 4.96 | — | up 100.74% | 13.3 | pass |
| OGN | Organon & Co. | Pharma & chemicals | $3.61B | 19.3 | 4.00 | 0.58% | up 1.55% | 63.1 | pass |
| RCUS | Arcus Biosciences, Inc. | Pharma & chemicals | $3.67B | — | 7.01 | — | up 3.87% | 20.8 | pass |
| AMLX | Amylyx Pharmaceuticals, Inc. Common Stock | Pharma & chemicals | $3.75B | — | 13.72 | — | up 66.17% | 13.3 | pass |
| IPAR | Interparfums, Inc. Common Stock | Pharma & chemicals | $3.76B | 22.3 | 4.27 | 2.73% | down 5.72% | 72.4 | pass |
| DNLI | Denali Therapeutics Inc. Common Stock | Pharma & chemicals | $3.77B | — | 4.07 | — | up 3.21% | 19.1 | pass |
| VKTX | Viking Therapeutics, Inc | Pharma & chemicals | $3.80B | — | 7.57 | — | up 3.28% | 8.1 | pass |
| ADPT | Adaptive Biotechnologies Corporation Common Stock | Pharma & chemicals | $3.98B | — | 18.40 | — | up 10.41% | 16.7 | pass |
| DBVT | DBV Technologies S.A. | Pharma & chemicals | $4.09B | — | 19.68 | — | up 2.37% | 9.0 | pass |
| DFTX | Definium Therapeutics, Inc. Common Shares | Pharma & chemicals | $4.13B | — | 14.82 | — | down 8.73% | 15.9 | pass |
| DYN | Dyne Therapeutics, Inc. Common Stock | Pharma & chemicals | $4.20B | — | 4.86 | — | up 0.99% | 16.6 | pass |
| CBT | Cabot Corporation | Pharma & chemicals | $4.27B | 12.9 | 2.72 | 2.23% | down 6.03% | 80.7 | pass |
| EWTX | Edgewise Therapeutics, Inc. Common Stock | Pharma & chemicals | $4.49B | — | 9.10 | — | up 8.69% | 18.0 | pass |
| ORKA | Oruka Therapeutics, Inc. Common Stock | Pharma & chemicals | $4.65B | — | 9.55 | — | down 4.03% | 21.6 | pass |
| ACAD | Acadia Pharmaceuticals Inc. | Pharma & chemicals | $4.95B | 12.7 | 3.96 | — | up 11.75% | 68.3 | pass |
| PRM | Perimeter Solutions, Inc. | Pharma & chemicals | $4.98B | — | 4.13 | — | down 0.36% | 22.3 | pass |
| CE | Celanese Corporation Common Stock | Pharma & chemicals | $4.98B | — | 1.23 | 0.26% | up 1.70% | 12.6 | pass |
| CSW | CSW Industrials, Inc. | Pharma & chemicals | $5.14B | 45.9 | 4.90 | 0.37% | down 3.13% | 43.0 | pass |
| AVNT | Avient Corporation | Pharma & chemicals | $5.38B | 65.7 | 2.24 | 2.49% | up 21.31% | 34.8 | pass |